Glofitamab
CAS: 2229047-91-8
Ref. 3D-FG184074
| 1mg | 1.062,00 € | ||
| 5mg | 3.540,00 € | ||
| 10mg | 5.663,00 € | ||
| 25mg | 10.618,00 € | ||
| 50mg | 15.927,00 € |
Información del producto
Glofitamab is a bispecific monoclonal antibody that binds to both CD20 and CD3 surface antigens found on B- and T-cells, respectively. It has a 2:1 configuration, with bivalency towards CD20 and monovalency towards CD3. By binding to both CD20 and CD3, it creates an immunological synapse that serves to recruit T-cells to CD20-expressing B-cells. This leads to T-cell activation and proliferation, secretion of cytokines, and the lysis of CD20-expressing B cells even under low effector-to-target cell ratios. Glofitamab is used for the treatment of diffuse large B-cell lymphoma.
This is a product for research use only.
Propiedades químicas
Consulta técnica sobre: 3D-FG184074 Glofitamab
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
